Sports Medicine Market Size, Strategies & Key Players Review by Forecast to 2030

Global Sports Medicine Market – Overview

Considering the rapid expansions the market is perceiving currently and the potential this market holds to grow further, Market Research Future (MRFR) recently published a study report, giving out a complete market insight for the period 2022 – 2030. In its analysis, MRFR asserts that the global Sports Medicine market size will reach up to 7.65 % CAGR during the review period (2022 – 2030).

Sports Medicine is an individual branch of medical dealing with the treatments, prevention, and diagnosis of the injuries and illness of athletics or sportsman. The global Sports Medicines market is well-established and growing pervasively. Increasing number of athletes and sportsmen coupled with the increasing incidences of sports injuries, increasing number of the sports medicine association, technological development and increasing awareness worldwide pushes the market to further heights.

Additionally, factors such as growing population, and urbanization coupled with the awareness towards the availabilities of Sports Medicines and its benefits are fostering market growth. Improving economic conditions across the globe enable access to the quality life, improving the healthcare, are providing impetus to the market

Moreover, R&D expenditure to bring novelties in the surgical instruments and development of better and effective materials for medical devices, etc. are driving the market growth to an extent. In the US & UK, among some other developed countries, medical treatments are quite costly, which, in turn, fuels the market growth of medical tourism in the developing economies such as India and Malaysia & others.

Conversely, factors such as unfavorable reimbursement policies are expected to inhibit the market growth of Sports Medicine, especially in the developed economies. Also, the majority of the people are unaware of the availability of sports medical centers coupled with the lack of skilled professionals for treating pediatric sports injuries are impeding the market growth. Availability of the limited number of well- experienced and trained physician and doctors in sports medicines is a growth hindering factor for the market.

Global Sports Medicine Market -Geographical Analysis

Geographically, North America accounted for the leading market for Sports Medicine, capturing 39 % of market share, valuing USD 1,883.6 Million in 2016, followed by the markets of Europe & Asia Pacific, respectively. The market is growing due to the significant contributions from the burgeoning market of the US backed by the high expenditure on healthcare coupled with the increasing prevalence of sports injuries and increasing number of sports medical centers. Moreover, growing demand for the Sports Medicine provides impetus to the market growth. Continuing with the same trends, the North America market is expected to create a larger revenue pocket in the global market by 2023.

On the other hand, Europe, the world’s second-largest market for Sports Medicine is driven by the high per capita income and well-established healthcare penetration in the region. The strong market growth in the countries like Germany & France drives the regional market growth large scale. With the increasing investment in healthcare and rising number of sports injuries, the market is projected to register a phenomenal CAGR.

Asia Pacific market for the Sports Medicine is expected to perceive an exponential growth owing to the growing markets of India & China backed by the vast population and the increasing number of sports medical centers in the region. Vietnam, Thailand, and Malaysia among the other South East Asian countries are projected to contribute significantly to the regional market growth. With the growing Medical Tourism markets in India & Malaysia, the APAC region will register a CAGR during the review period.

Global Sports Medicine Market –Competitive Analysis

The global Sports Medicine market appears to be fiercely competitive and fragmented with many well-established players having the global presence. Brand reinforcement, mergers & acquisitions, and innovation remain the popular trends for the key players in the market.

Global Sports Medicine Market –Segmentations

MRFR has segmented the Sports Medicine Market into Five key dynamics

By Products   : Comprising Flavors Support & Recovery Products, Joint Reconstructive & Repair Products, and Accessories & Consumables, among others.

By Applications         : Knee Treatment, Shoulder Treatment, Hip Treatment, and Spine Treatment, among others.

By Procedures           : Tendon to Bone, Tendinosis, and Cartilage Repair, among others.

By End-Users : Trauma Centers, Hospitals & Emergency Care, and Ambulatory Care, among others.

By Regions                 :  North America, Europe, APAC and Rest of the World.    

Segment Tendinosis by procedures commands the largest share market of 54% in global sports medicine market.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Influenza Diagnostics Market Outlook: SWOT Analysis, And Key Industry Developments

Market Overview

Market Research Future (MRFR) has published a report about the global influenza diagnostics market share expects 5.3% CAGR during the forecast period between 2023-2032. In terms of cash, this market is expected to grow with USD 1.81 billion by 2032. This report analyzes the market, potential for growth during the forecast period, market sizes around the world, key players in the market, product launches and latest research and development (R&D).

Influenza as an illness can cause severe complications and mess up anybody's medical history. Influenza is of various types and with a variety of deadly symptoms. Hence, early diagnosis of influenza can reduce the chances of further complications. Therefore, with World Health Organization (WHO) confirming about 600 million Influenza cases worldwide, the services offering accurate Influenza diagnosis are going to be in-demand always and become a part of a huge market in the medical sector.

Regional Analysis

The regional segmentation of the global influenza diagnostics market insight is into the Americas (North America & South America), Europe, Asia Pacific, and Middle East & Africa (MEA). North America is believed to be the largest market for global influenza diagnostics due to advanced healthcare facilities and the increasing presence of major market players in this region. Compared to North America, South America is a moderately smaller market, but that is not due to lack of demand but due to the lack of awareness, lack of advanced technology and lesser budgets for healthcare. In North America, the largest markets are Canada and the United States of America (USA).

After North America, Europe is the largest market for influenza diagnostics. Here due to reasons same as North America, Western Europe stands with the lion's share in Europe market, compared to Eastern Europe. In Western Europe, the biggest markets are France, Germany, Italy, Spain and the United Kingdom (UK), followed by the rest of Europe.

During the forecast period, Asia Pacific region is expected to experience large-scale growth of influenza diagnostics market with China, India, Japan and South Korea emerging as major markets. Remarkable growth is also expected in remaining countries of Asia Pacific region.

 However, compared to the Asia Pacific, MEA is expected to have limited growth, with Egypt, Saudi Arabia and the United Arab Emirates (UAE) emerging as the best bets for influenza diagnostics market investors. The low market in the MEA region is primarily due to the lack of technology and education.

Key Players

Global influenza diagnostics market players include

Alere (USA),

 BD (USA),

Becton Dickinson (USA),

BioMérieux SA (France),

Cepheid (USA),

Hardy Diagnostics(USA),

LifeSign LLC.(USA),

Meridian Bioscience, Inc.(USA),

Quidel Corporation (USA),

Roche Molecular Systems Inc.(Switzerland), and

Sekisui Diagnostics (USA).

Market Segmentation

The global influenza diagnostics market outlook is segmented on the basis of types, tests, and region. The segmentation of types comprises of type A flu, type B flu, type C flu. The three forms of type A are bird flu, seasonal flu, and Swine flu. Bird Flu is known as Avian Influenza which is caused by viruses adapted to birds. It can be caused by eating infected birds. Seasonal flu is common cold whose viruses become active only during the change of seasons as human body becomes adapt to the new season slowly. Similar to bird flu, swine flu is an infection caused by any one of several types of swine influenza viruses. Swine influenza virus (SIV) or swine-origin influenza virus (S-OIV) are the viruses causing this infection. These viruses are found in pigs. Type B flu is found only in humans. Influenza type B viruses are not classified by subtype and do not cause pandemics. It is caused by a genus called Influenzavirus B which is from the virus family Orthomyxoviridae. Type C Influenza viruses are from Orthomyxoviridae family. They are not as severe as Type A or B but can cause local epidemics.

On the basis of tests, the market has been segmented into direct fluorescent antibody (DFA) tests, molecular tests, nucleic acid sequence-based amplification (NASBA) tests, rapid influenza detection tests (RIDT), serological assays, simple amplification-based assays (SAMBA) and loop-mediated isothermal amplification-based assays (LAMP). RITD is the most common test for influenza, as it can confirm influenza in just 30 minutes.

Serological assays are segmented into primary serological tests, secondary serological tests, and tertiary serological tests. Primary serological tests cover enzyme-linked immunosorbent assay (ELISA), immunofluorescent antibody technique (IFAT) and radioimmunoassay (RIA). Secondary Serological tests include agglutination tests, complement fixation tests (CFT), precipitation tests, serum neutralization tests (SNT) and toxin-antitoxin test.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Cardiac Pacemaker Market Outlook: growth, drivers and forecast report by 2030

Overview:

The global cardiac pacemaker market share is projected to reach USD 5.8 billion by 2030 at a 3.20% CAGR during the forecast period 2022-2030. This certain growth can be attributed to several factors from its functional features to its use in countering diverse health-related issues. Cardiac pacemakers use in maintaining regularity of the heart rhythm by sending electrical pulses to the heart has gained traction in treating atrial fibrillation (AFib) which is also the chief driver in taking the cardiac pacemaker market ahead. Furthermore, the rising geriatric population, with a predicted number of 2.1billion by 2050, is expanding the cardiac pacemaker market horizon.

However, cardiac pacemakers incur high cost which can be a hurdle for the cardiac pacemaker market during the forecast period. At the same time, its implantation procedure requires surgery and risks of malfunctioning can add further woe.

Market Insight:

The cardiac pacemaker market has several global players who engage in strategic developments to ace the field. These developments include merger, acquisition, collaboration, new product launch, and other methods. For instance, Medtronic is acquiring shares in Chinese company LifeTech Scientific to gain hold of the Chinese market. Stryker, on the other hand, is trying to buy Boston Scientific Corporation in a bid to expand their portfolio.

The global cardiac pacemaker market players are Medtronic (U.S.), Abbott. (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK (Germany), LEPU MEDICAL (U.K), SORIN Group (Europe), MEDICO S.p.A. (Europe), OSCOR Inc. (U.S.), and others.

Segmentation Analysis:

The global cardiac pacemaker market outlook can be segmented by type, technology, application, and end-users.

Based on type, the cardiac pacemaker market includes implantable, external cardiac pacemaker, and others.

Technology-wise, the cardiac pacemaker market comprises biventricular, single-chambered, dual-chambered, and others.

Application-based segmentation of the cardiac pacemaker market consists arrhythmias, congestive heart failure, and others. Arrhythmias segment can be sub-segmented into tachycardia, bradycardia, and others.

Based on the end-users, the market cardiac pacemaker includes hospitals, cardiac care centers, medical institutes, and others.

Industry Trend:

Researchers at the University of Ottawa Heart Institute completed the first successful implant in 2018 of a Micra Leadless Transcatheter Pacing System, which is the latest model of its category and the smallest leadless pacemaker in the world. The process allows the machine to be implanted directly within the heart, unlike other pacemakers. 

Practitioners at Children's Hospital Los Angeles and the University of Southern California have developed a micropacemaker system requiring implantation in the pericardial sac which could be a breakthrough in cardiac surgery options for children and adults.

Regional Analysis:

Cardiac pacemaker market insights includes regions namely the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

The Americas has the lead in the global market, and they can attribute this to a superior infrastructure, and better healthcare policies. Furthermore, a considerable patient pool is also playing in favor of cardiac pacemaker market. Changing lifestyle and high healthcare expenditure are proving essential for the regional market growth.

Europe is following the lead and is experiencing considerable growth owing to regular investment in research and development. Governments taking a keen interest in the sector has a positive impact on the market.

The APAC is the fastest growing region with India and China continually improving their industrial landscape. In addition, many countries of this region are emerging as a medical tourism hub and helping the regional cardiac pacemaker market witness unprecedented growth. The MEA region’s growth will be slow due to lack of infrastructure and poor economic regions.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Flow Cytometry Market Outlook, Size, Share & Key Companies by 2032

Flow Cytometry Market – Overview

The rising demand for clinical and scientific research has raised the requirement for flow cytometry. Market reports associated to the healthcare industry have been made available by Market Research Future which creates reports on other industry verticals that outlines the current market scenarios. The Flow Cytometry Market share is predicted to grow at a CAGR of 8.2% in the forecast period 2023-2032.

The rising adoption of innovative technology is expected to impact the market positively. The healthcare sector is one of the major end users of the flow cytometry market. The intensifying occurrences of HIV and cancer cases which have to be the diagnosed correctly are fuelling the expansion of the market. The market is anticipated to evolve further due to demand from hematology, transplantation, genetics and prenatal diagnosis in the upcoming forecast period.

Detailed Regional Analysis 

The Americas region is likely to control the flow cytometry market insights due to the incidence of a well-established healthcare system, implementation of highly advanced technology and rise in the number of patients suffering from autoimmune diseases in the region. The European region is projected to be the next principal flow cytometry market. The market progress in this region can be credited to government funding and support to the research and development activities, rising awareness about healthcare diagnostics and growing cases of cancer patients in the region. Besides, the collective research and development activities in the pharmaceutical industry is also adding to the growth of the market in this region. The Asia Pacific region is estimated to be the swiftest growing flow cytometry market through the forecast period due to the growing prevalence of autoimmune diseases, growing awareness about healthcare and mounting investments and collaborative activities in healthcare in the region. The market in the Middle East & Africa region is projected to control the smallest share of the market owing to an underdeveloped healthcare sector, deficiency of technical knowledge, and poor medical facilities.

Competitive Analysis

The diversification of the product assortment in the market is increasing the opportunity for the progress of the market. The market is at an optimally productive level and will be capable of generating greater value for the firms in the market and its shareholders. The management inclinations in the market are reinforcing the level of growth that can be achieved in the present market scenario. Although, the market has also considerably neutralized the market advantages and thus is promoting an increase in the number of firms in the market. The progress paths are reviewed in tandem to the customer likings to realize the highest growth, and in the long run, viability. The skill to utilize the economies of scale is further proving to be beneficial for comprehensive market growth.  

The flow cytometry market players are Becton, Dickinson and Company., Beckman Coulter, Inc., Danaher., Thermo Fisher Scientific, Luminex Corporation., Miltenyi Biotec, Merck KGaA, Bio-Rad Laboratories, Inc., Sysmex Partec GmbH, Sony Corporation, Agilent Technologies, Inc., Biomérieux S.A., and Enzo Biochem Inc.

Segmental Analysis

The flow cytometry market outlook has been segmented on the basis of technology, products & services, application, and end-user. By products & services, the market has been segmented into flow cytometry reagents and consumables, services, software, instruments, and accessories. On the basis of technology, the market has been divided into bead-based flow cytometry and cell-based flow cytometry. The application segment of the flow cytometry market comprises of research applications, clinical applications, and industrial applications. The research applications segment has been segmented further segmented into biotechnology, pharmaceutical, and immunology. The flow cytometry by end user has been segmented into research institutes, hospitals and clinics, commercial, and academic institutes. The market has been segmented by region into Europe, the Americas, Asia Pacific, and the Middle East & Africa.

Related reports-

Autism Disorder and Treatment Market Research Report - Forecast to 2030

Medical Supplies Market Research Report-Forecast To 2030

Saliva Collection & Diagnostics Market Research Report - Forecast till 2027

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Auto-Injector Market Size is forecasted to grow during forecast year 2032

 

Auto-Injectors Global Market – Overview

Global Auto-Injectors market size is expected to reach USD 8.80 billion by 2032 and is expected to grow at a CAGR of 14.2% during the forecast period 2023 – 2032. The global market for auto-injectors is growing rapidly. Increasing prevalence and incidences of anaphylaxis and food allergies around the world is majorly responsible for the growth of the global auto-injectors market.  According to the recent Market Study Report “Global Auto-Injectors Market” published by the Market Research Future.

Auto-injectors are spring-loaded syringes, designed to deliver a single dose of a particular life-saving drug. Auto injectors, as the name suggests, are easy to use and are intended for self –administration by patients, or can be administered by untrained personnel. These injectors were initially designed to overcome the hesitation associated with self-administration of the needle-based drug delivery device. Most of the injectors are spring-loaded based.

In an Auto injector the needle tip is covered/ shielded prior to injection, Injection depth can be adjustable with a passive safety mechanism to prevent accidental injection. At the touch of a button, Auto injector automatically inserts the needle and contents of the syringe into the skin without the user having to see the needle. Auto-injectors not only allow the automatic injection of the syringe but also have a visual indication to confirm that the full dose has been delivered, factors as such affirm that Auto injectors are completely safe and reliable for the self-administration of drug delivery and are preferred over the traditional syringe among the needle-based drug delivery devices.

Auto-Injectors Market Regional Analysis

Globally North America is the largest market for auto-injectors.

Europe is the second-largest market for auto-injectors. Asia pacific region is expected to be fastest growing region in auto-injectors market.

Growth of biologics and entry of biosimilar in leading pharma markets such as the U.S. and Europe is expected to be the key driver for growth of the injectable drug delivery market for the forecast period.

Auto-Injectors Global Market - Key Players

While commenting upon this deep diving study report, presented through more than 100 market data tables and figures, widely spread over 85 pages, the MRFR Research Analyst also mentions that Auto injectors normally are made of glass syringes making them fragile and a probable cause of contamination. Currently, the players of the market are striving to create auto injectors syringes with plastic to prevent unnecessary contamination, confirms MRFR Analysis. 

MRFR Analysis identifies following corporations as the key players operating in the global market of auto injectors some of them are:

• UNILIFE CORPORATION,
• Scandinavian Health Ltd,
• Owen Mumford Ltd. (UK),
• kaleo, Inc.,
• Amedra Pharmaceuticals LLC,
• Enbrel and others.

Auto-Injectors Global Market - Segments:

Auto-Injectors Market has been segmented in to 3 key dynamics for an enhanced understanding and convenience of the report.

Segmentation by Product Type          : Comprising - Disposable, Reusable and others

Segmentation by Application             : Comprising - Anaphylaxis, Allergies, Multiple Sclerosis, Rheumatoid Arthritis and others

Segmentation by suppliers                : Comprising - Online Retailers, Pharmacy, Retailers

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Drug Device Combination Market Share, Insights and Forecast to 2032

Market Analysis

The global drug device combination market share is predicted to grow at a whopping 7.2% CAGR over the assessment period 2023-2032. Drug-device combination products relate a drug with that of a medical device to bridge various regulatory frameworks (device or drug). This can be a single product having several components such as drug-eluting stents, transdermal patches or products that are separately packed yet intended for use exclusively with a definite counterpart. Drug-device combination products offer an array of advantages namely targeted drug delivery, improved patient compliance, controlled drug administration and minimal side effects. Owing to its increased sophistication and different advantages, drug device combination products are widely adopted all across the medical sector.

There are plentiful factors that is boosting the growth of the drug device combination market. These factors as per the Market Research Future (MRFR) report include increasing incidences of urology, prostate cancer, diabetic neuropathy, colorectal cancer, respiratory problems and cardiovascular diseases, growing healthcare expenditure, increasing awareness of market products, growing geriatric population, technological advancements in the drug-device combination product, increase in homebased healthcare market, high market potential, and increase in healthcare expenditure. On the contrary, side effects, existence of low-income countries, soaring price of products, strict government rules for the approval of these devices and errors and post-complications leading to various product recalls are factors that may deter drug device combination market growth.

Key Players

Drug device combination market players profiled in the industry include

Zimmer Holding, Inc,

Wright Medical Group, Inc.,

Stryker Corporation,

St. Jude Medical Inc,

Smith & Nephew Plc,

Covidien Ltd,

Cook Critical Care, Inc.,

C.R. BARD, Inc.,

Boston Scientific Corporation,

Biotronik,

Biometrix Medical,

Biomet Orthopedics, Inc,

AlloSource,

Abbott Laboratories,

3M, and others.

Market Segmentation

MRFR report provides an extensive segmental analysis of the drug device combination market outlook on the basis of product, application and end-users.

Based on product, it is segmented into advanced wound care products, catheter and others. Catheter is again segmented into wound drainage catheter, thermodilution catheters, oximetry catheters, cardiovascular catheters, urological catheters, antimicrobial catheter and others. Advanced wound care products are again segmented into photodynamic therapy, drug eluting stents, antibiotic bone cements, bone graft substitutes and antibiotic wound care. Bone graft substitutes is again segmented into cell-based bone graft substitutes, allograft-based bone graft substitutes, ceramic based bone graft substitute and others.

Based on application, the drug device combination market is segmented into ophthalmic treatment, wound care, antimicrobial applications, bone treatment, peripheral arterial disease, non-cardiovascular treatments, tachycardia management, coronary angioplasty and others.

Based on end-users, it is segmented into academic and research organization, ambulatory centers, hospitals and clinics and others.

Regional Analysis

By region, the drug device combination market insights covers growth opportunities and latest trends across the Americas, Europe, Asia Pacific and Middle East and Africa. Of these, the Americas will sway the market over the assessment period owing to increasing incidence of cardiovascular diseases, presence of key market players, developed healthcare sector in Canada and the US, high healthcare expenditure and suitable reimbursement policies. In the European region, the drug device combination market will have the second major share due to huge patient pool, presence of developed economies, increasing awareness about the device and presence of healthcare infrastructure that is well-developed. In the APAC region, the drug device combination market is expected to grow at the fastest pace owing to growing support from the government for foreign investments, growing healthcare sector and growing penetration of market players here. On the other hand, the drug device combination market in the Middle East and Africa will have minimal share in the market owing to low per capita income and presence of poor economies. The Middle East is anticipated to have a major share in the drug device combination market owing to presence of developed economies such as Dubai, Saudi Arabia, United Arab Emirates and others and increasing funds made by the government in the healthcare sector.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Smart Insulin Pens Market Size, Strategies & Key Players Review by Forecast to 2030

 Smart Insulin Pens Market Highlights

The Smart Insulin Pens Market Size was worth USD 0.13 Billion in 2023 and is expected to reach USD 0.26 Billion by 2030 at 11.77% CAGR during the forecast period 2022 - 2030. As per smart insulin pens market analysts, the global market is anticipated to witness growth owing to the factors such as alarming escalation in diabetes cases as well as the escalating pool of diabetics considering surge in obesity. However, the smart insulin pens market will face challenges and restraints due to product recall and the amplified product quality issues during the forecast period 2022 to 2030.

Sedentary lifestyles and aging in the smart insulin pens market is set to play a key role in determining the growth potential during 2022 to 2030 years. Analysts have also studied the smart insulin pens market to understand potential threats and challenges the smart insulin pens market companies could face. Although the smart insulin pens market trends is poised to grow at a fast pace across product type and end-users’ segments, factors such as strict rules and regulations could slow down the smart insulin pens market's growth worldwide.

Competitive Landscape

Smart insulin pens have seen increased demand over the years, due to the commonness of unhealthy eating habits and lifestyles and the collective surge noted in product approvals. Companies functioning in the global smart insulin pens market are also being challenged due to stringent rules and concerns regarding the approval process. Mergers and acquisitions by smart insulin pens market companies are anticipated to help the market during the forecast period 2018 to 2023. As the smart insulin pens market is set to register a high CAGR of 6.92% and is also anticipated to reach a US$23,624.01 million by 2025, the report highlights key areas companies need to focus on. The report suggests that the smart insulin pens market will see a healthy growth in the long run till 2023. Based on SWOT analysis and smart insulin pens market’s analysis based on Porters’ Five Force Model presented in the smart insulin pens market report. Mergers and acquisitions by smart insulin pens market companies are anticipated to help the market during the forecast period 2018 to 2023. 

MRFR recognizes the Global Smart Insulin Pens Market Players are Companion Medical, Eli Lily and Company, Diamesco Co., Ltd., Ypsomed Holding AG, Emperra GmbH E-Health Technologies, Digital Medics Pty Ltd., and Novo Nordisk A/S and Others.

Market Segmentation

The market for smart insulin pens market insights has been segmented into product type and end-users. Based on the segment, which is product type, the market is categorized based on smart pen and connecting device. The global market for smart insulin pens is further segmented based on end-users into hospital/retail pharmacies and online.

The global market research report covers all the aspects of the smart insulin pens market based on the segmental analysis of these product types and end-users’ segments. Analysts have also studied the global smart insulin pens market's regional markets spread across many continents and countries. The product type and end-users’ segments along with their sub-segments have been analysed and companies functioning in the smart insulin pens market across these segments are profiled and analysed based on input and feedback from smart insulin pens industry-based decision makers as well as primary and secondary sources. The smart insulin pens market research report presents analysis-based information for companies functioning in the smart insulin pens market.

Regional Overview

New government rulings or hospital strategies in the wake of the pandemic may hinder the smart insulin pens market growth. The market research report suggests that companies in the smart insulin pens industry could be supported by broadening insurance coverage as well as the massive population suffering from diabetes during the forecast period. The smart insulin pens market is set to register growth at a high CAGR owing to these key factors. The market for smart insulin pens is spread across North America, Europe, Asia-Pacific, and other parts of the world. The global smart insulin pens market research report reveals that APAC, North America, and Europe regional smart insulin pens markets will dominate the global market for smart insulin pens during the forecast period 2018 to 2023. As per smart insulin pens market analysts, the market is set to witness tremendous growth across devices as well as hospitals and clinics segments in North America which covers smart insulin pens markets across the United States, Canada, Mexico, and several other regional markets. Companies active in the smart insulin pens market are also analysed and studied in the smart insulin pens market research report.

The smart insulin pens industry for Europe covers smaller market segments of Germany, Italy, France, and the United Kingdom. Additionally, the smart insulin pens market research report covers the Asia-Pacific region covering smart insulin pens markets from India, China, Japan, Australia, and others. The smart insulin pens market is also spread across the rest of the world. The smart insulin pens market report covers all such regions including the Middle East, Africa, Brazil, and others.

Industry News

Medtronic, a world pioneer in medical devices, revealed today that it will acquire privately owned Companion Medical, the maker of InPen, the only FDA-approved smart insulin pen device with an embedded diabetes care app on the marketplace. The inclusion of Companion Medical's InPen to Medtronic's portfolio broadens the company's potential to help patients at every stage in their disease path and provide them with a unique and vast ecosystem of assistance — independent of how insulin is administered. Companion Medical's acquisition draws on strong algorithms that take advantage of the corporation's deep data analytics and Artificial intelligence.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com